https://www.ajmc.com/view/dr-joshua-sabari-on-burden-treatment-options-for-patients-with-kras-mutated-nsclc
Joshua Sabari, MD, a thoracic medical oncologist, Perlmutter Cancer Center, NYU Langone Health, discusses actionable mutations in advanced non–small cell lung cancer (NSCLC).
Create an account or login to join the discussion